Lantern Pharma Inc.
LTRN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001763950
No open-market purchases or sales by Lantern Pharma Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $12.0M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Lantern Pharma Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 27 | 30 | +3 |
| Shares | 1.15M | 1.16M | +1.55K (+0.1%) |
| Value | $3.93M | $4.94M | +$1.01M (+25.7%) |
New holders (3)
Institutions that held Lantern Pharma Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Dimensional Fund Advisors LP | 11,828 | $50.6K | 0.00% |
| Morgan Stanley | 600 | $2.57K | 0.00% |
| Bank of America Corp | 5 | $21 | 0.00% |
Sold out (0)
Institutions that held Lantern Pharma Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
None.